首页> 外文会议>International conference on the development of biomedical engineering in Vietnam >Techniques for the Incorporation of Fluorine-18 and Carbon-11
【24h】

Techniques for the Incorporation of Fluorine-18 and Carbon-11

机译:用于掺入氟-18和碳-11的技术

获取原文

摘要

Molecular imaging is an attractive modality that has been widely employed in many aspects of biomedical research, especially those aimed at the early detection of diseases such as cancers, inflammation and neurodegenerative disorders. One specific type of molecular imaging, which has shown a renewed interest in recent years, comes in the form of positron emission tomography (PET). This type of imaging relies on the formation of small molecule drugs that have been selectively labeled with a positron emitting radionuclide. Ide-aliy, the small molecule will have a high affinity for the mo-lecular target, cell line or physiological process to be imaged, which allows for the accumulation of the agent. The predict-able mode and rate of decay associated with the chosen nuclide allows for both spatial and quantitative imaging of the tissues associated with the small molecule radiotracer when con-trasted against the surrounding tissue that lacks the character-istic radioactive decay. Over the many years of radiotracer development, various methods for the incorporation of the radionuclide have been discovered and utilized. Much of this experimentation has shed light on the types of reaction sub-strates, solvents, temperatures and reactant forms that allow for the most efficient and repeatable labeling of a given class of molecule. This paper will highlight many of the previously attempted, currently used and potential reactions for the in-corporation of either fluorine-18 or carbon-11 radionuclides onto both small molecule and macromolecular drugs. This will include both aliphatic and aromatic labeling techniques and the types of products and potential by-products one may ob-serve.
机译:分子成像是一种吸引人的模态,其在生物医学研究的许多方面被广泛采用,特别是那些旨在早期发现癌症,炎症和神经变性障碍等疾病的方面。一种特异性类型的分子成像,近年来迄今为止兴趣,以正电子发射断层扫描(PET)的形式出现。这种类型的成像依赖于形成用正电子发射放射核素选择性标记的小分子药物的形成。 IDE-ALIY,小分子将对待成像的Mo卵形靶,细胞系或生理过程具有高亲和力,这允许累积药剂。与所选核素相关的预测模式和衰减速率允许与小分子放射体蛋白相关的组织的空间和定量成像,当追溯到缺乏字符 - istic放射性衰减的周围组织时。在多年的放射性机构的发展中,已经发现并利用了各种用于掺入放射性核素的方法。这些实验中的大部分都在反应亚胞胎,溶剂,温度和反应物形式的类型上脱光,其允许给定类别的最有效和可重复的标记。本文将突出氟-18或碳-11放射性核素的氟-18或碳-11放射性核素的含量上的许多先前尝试,目前使用和潜在的反应在小分子和大分子药物上。这将包括脂族和芳族标记技术和产品类型和潜在的副产品,可以ob-sever。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号